Skip to main content
Erschienen in:

11.09.2024 | Original articles

Radiological changes in the thymus in patients who have had COVID-19 and in vaccinated persons who have not had COVID-19: a CT study

verfasst von: Berin Tuğtağ Demir, PhD, Melike Ruşen Metin Söğütlügil, Fatih Çankal

Erschienen in: Die Radiologie | Sonderheft 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

There are very few and limited studies on the role of the thymus in COVID-19 infection. It is known that thymus morphology changes in individuals vaccinated against COVID-19 although they do not have active infection.

Objective

Our study aims to evaluate these differences in detail.

Methods

This research was conducted in a total of 141 people, 75 women and 66 men. The research consisted of three groups: unvaccinated persons who have had the disease (n = 49), vaccinated persons who have not had the disease (n = 37), and unvaccinated persons who have not had the disease (control group, n = 55). In the study, the thymus volume, structure, and fat content were investigated and the differences between groups were evaluated.

Results

Thymus volume was greatest (0.43 ± 0.11) in the vaccinated group that had not had the disease and smallest (0.15 ± 0.07) in the unvaccinated group that had had the disease, and a significant difference was found between the groups. Thymus steatosis was seen mostly in the unvaccinated group that had had the disease (72%; p = 0.04). The diffuse nodular pattern was only present in the diseased group.

Conclusion

This research is the first study in the literature to date on the effect of COVID-19 and vaccines on the thymus. In addition to the acute consequences of the virus, the possibility of negative symptoms after COVID-19 should also be kept in mind, especially in unvaccinated people. Further studies are needed to confirm the results reported herein.
Literatur
1.
Zurück zum Zitat Simanovsky N, Hiller N, Loubashevsky N, Rozovsky K (2012) Normal CT characteristics of the thymus in adults. Eur J Radiol 81(11):3581–3586CrossRefPubMed Simanovsky N, Hiller N, Loubashevsky N, Rozovsky K (2012) Normal CT characteristics of the thymus in adults. Eur J Radiol 81(11):3581–3586CrossRefPubMed
2.
Zurück zum Zitat Kellogg C, Equils O (2021) The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization. Hum Vaccin Immunother 17(3):638–643CrossRefPubMed Kellogg C, Equils O (2021) The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization. Hum Vaccin Immunother 17(3):638–643CrossRefPubMed
4.
Zurück zum Zitat Tresckow JV, Tresckow BV, Reinhardt HC, Herrmann K, Berliner C (2021) Thymic hyperplasia after mRNA based Covid-19 vaccination. Radiol Case Rep 16(12):3744–3745CrossRef Tresckow JV, Tresckow BV, Reinhardt HC, Herrmann K, Berliner C (2021) Thymic hyperplasia after mRNA based Covid-19 vaccination. Radiol Case Rep 16(12):3744–3745CrossRef
5.
Zurück zum Zitat Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA et al (2018) Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol 8:1960CrossRefPubMedPubMedCentral Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA et al (2018) Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol 8:1960CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Cuvelier P, Roux H, Couëdel-Courteille A, Dutrieux J, Naudin C et al (2021) Reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome. Crit Care 25(1):4–8CrossRefPubMedPubMedCentral Cuvelier P, Roux H, Couëdel-Courteille A, Dutrieux J, Naudin C et al (2021) Reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome. Crit Care 25(1):4–8CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034CrossRefPubMedPubMedCentral Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Luo XH, Zhu Y, Mao J, Du RC (2021) T cell immunobiology and cytokine storm of COVID-19. Scand J Immunol 93:e12989CrossRefPubMed Luo XH, Zhu Y, Mao J, Du RC (2021) T cell immunobiology and cytokine storm of COVID-19. Scand J Immunol 93:e12989CrossRefPubMed
10.
Zurück zum Zitat Sahin D, Tanacan A, Erol SA, Anuk AT, Yetiskin FDY, Keskin HL et al (2021) Updated experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: a prospective cohort study from Turkey. Int J Gynaecol Obstet 152:328–334CrossRefPubMed Sahin D, Tanacan A, Erol SA, Anuk AT, Yetiskin FDY, Keskin HL et al (2021) Updated experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: a prospective cohort study from Turkey. Int J Gynaecol Obstet 152:328–334CrossRefPubMed
11.
Zurück zum Zitat Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S (2020) Cytokine storm in COVID-19: pathogenesis and overview of antiinflammatory agents used in treatment. Clin Rheumatol 39:2085–2094CrossRefPubMedPubMedCentral Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S (2020) Cytokine storm in COVID-19: pathogenesis and overview of antiinflammatory agents used in treatment. Clin Rheumatol 39:2085–2094CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ayhan Goncu S, Turgut E, Oluklu D, Ozden Tokalioglu E, Menekse Beser D, Moraloglu TO, Sahin D (2021) Influence of Covid-19 infection on fetal thymus size after recovery. J Perinat Med 50(2):139–143CrossRef Ayhan Goncu S, Turgut E, Oluklu D, Ozden Tokalioglu E, Menekse Beser D, Moraloglu TO, Sahin D (2021) Influence of Covid-19 infection on fetal thymus size after recovery. J Perinat Med 50(2):139–143CrossRef
13.
Zurück zum Zitat Uyan HD, Oluklu D, Menekse Beser D, Yildirim M, Tugrul ED, Tanacan A, Sahin D (2023) Evaluation of fetal thymus size in maternal autoimmune diseases: systemic lupus erythematosus, Sjögren’s syndrome and antiphospholipid antibody syndrome. Arch Gynecol Obstet 10(4):1–7 Uyan HD, Oluklu D, Menekse Beser D, Yildirim M, Tugrul ED, Tanacan A, Sahin D (2023) Evaluation of fetal thymus size in maternal autoimmune diseases: systemic lupus erythematosus, Sjögren’s syndrome and antiphospholipid antibody syndrome. Arch Gynecol Obstet 10(4):1–7
14.
Zurück zum Zitat De Felice C, Toti P, Musarò M, Peruzzi L, Paffetti P, Pasqui L et al (2008) Early activation of the hypothalamic-pituitary-adrenal-axis in very-low-birth-weight infants with small thymus at birth. J Matern Fetal Neonatal Med 21:251–254CrossRefPubMed De Felice C, Toti P, Musarò M, Peruzzi L, Paffetti P, Pasqui L et al (2008) Early activation of the hypothalamic-pituitary-adrenal-axis in very-low-birth-weight infants with small thymus at birth. J Matern Fetal Neonatal Med 21:251–254CrossRefPubMed
15.
Zurück zum Zitat Kuypers E, Wolfs TG, Collins JJ, Jellema RK, Newnham JP, Kemp MW et al (2013) Intraamniotic lipopolysaccharide exposure changes cell populations and structure of the ovine fetal thymus. Reprod Sci 20:946–956CrossRefPubMedPubMedCentral Kuypers E, Wolfs TG, Collins JJ, Jellema RK, Newnham JP, Kemp MW et al (2013) Intraamniotic lipopolysaccharide exposure changes cell populations and structure of the ovine fetal thymus. Reprod Sci 20:946–956CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Baron R, Lee J, Sagel S, Peterson R (1982) Computed tomography of the normal thymus. Radiology 142(1):121–125CrossRefPubMed Baron R, Lee J, Sagel S, Peterson R (1982) Computed tomography of the normal thymus. Radiology 142(1):121–125CrossRefPubMed
17.
Zurück zum Zitat Araki T, Nishino M, Gao W, Dupuis J, Hunninghake GM, Murakami T, Washko GR, O’Connor GT, Hatabu H (2016) Normal thymus in adults: appearance on CT and associations with age, sex, BMI and smoking. Eur Radiol 26(1):15–24CrossRefPubMed Araki T, Nishino M, Gao W, Dupuis J, Hunninghake GM, Murakami T, Washko GR, O’Connor GT, Hatabu H (2016) Normal thymus in adults: appearance on CT and associations with age, sex, BMI and smoking. Eur Radiol 26(1):15–24CrossRefPubMed
18.
Zurück zum Zitat Rehman S, Majeed T, Ansari MA, Ali U, Sabit H, Al-Suhaimi EA (2020) Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response. Saudi J Biol Sci 27(10):2567–2573CrossRefPubMedPubMedCentral Rehman S, Majeed T, Ansari MA, Ali U, Sabit H, Al-Suhaimi EA (2020) Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response. Saudi J Biol Sci 27(10):2567–2573CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ (2020) SARS.-CoV‑2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience 42:505–514CrossRefPubMedPubMedCentral Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ (2020) SARS.-CoV‑2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience 42:505–514CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR (2021) Aging, immunity, and COVID-19: how age influences the host immune response to Coronavirus infections? Front Physiol 11:571416CrossRefPubMedPubMedCentral Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR (2021) Aging, immunity, and COVID-19: how age influences the host immune response to Coronavirus infections? Front Physiol 11:571416CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Al-Suhaimi EA, Aljafary MA, Alkhulaifi FM, Aldossary HA, Alshammari T, AL-Qaaneh A, Aldahhan R, Alkhalifah Z, Gaymalov ZZ, Shehzad A et al (2021) Thymus gland: a double edge sword for Coronaviruses. Vaccines 9:1119CrossRefPubMedPubMedCentral Al-Suhaimi EA, Aljafary MA, Alkhulaifi FM, Aldossary HA, Alshammari T, AL-Qaaneh A, Aldahhan R, Alkhalifah Z, Gaymalov ZZ, Shehzad A et al (2021) Thymus gland: a double edge sword for Coronaviruses. Vaccines 9:1119CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Nakhlband A, Fakhari, Azizi AH (2021) Interferon-beta offers promising avenues to COVID-19 treatment: a systematic review and meta-analysis of clinical trial studies. Naunyn Schmiedebergs Arch Pharmacol 394:829–838CrossRefPubMedPubMedCentral Nakhlband A, Fakhari, Azizi AH (2021) Interferon-beta offers promising avenues to COVID-19 treatment: a systematic review and meta-analysis of clinical trial studies. Naunyn Schmiedebergs Arch Pharmacol 394:829–838CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat von Tresckow J, von Tresckow B, Reinhardt HC, Herrmann K, Berliner C (2021) Thymic hyperplasia after mRNA based Covid-19 vaccination. Radiol Case Rep 16(12):3744–3745CrossRef von Tresckow J, von Tresckow B, Reinhardt HC, Herrmann K, Berliner C (2021) Thymic hyperplasia after mRNA based Covid-19 vaccination. Radiol Case Rep 16(12):3744–3745CrossRef
25.
Metadaten
Titel
Radiological changes in the thymus in patients who have had COVID-19 and in vaccinated persons who have not had COVID-19: a CT study
verfasst von
Berin Tuğtağ Demir, PhD
Melike Ruşen Metin Söğütlügil
Fatih Çankal
Publikationsdatum
11.09.2024
Verlag
Springer Medizin
Erschienen in
Die Radiologie / Ausgabe Sonderheft 1/2024
Print ISSN: 2731-7048
Elektronische ISSN: 2731-7056
DOI
https://doi.org/10.1007/s00117-024-01363-4

Neu im Fachgebiet Radiologie

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

PMBCL mit CMR: Radiatio kann ohne Risiko weggelassen werden

Patienten mit primär mediastinalem B-Zell-Lymphom (PMBCL), die nach der Induktionstherapie eine komplette metabolische Remission (CMR) erreichen und keine konsolidierende Bestrahlung erhalten, müssen offenbar keine Überlebensnachteile fürchten.

Hypoxisch-ischämische Enzephalopathie: Indikatoren für eine ungünstige Prognose

Eine US-amerikanische Studie widmete sich der Identifizierung prognostischer Parameter bei Neugeborenen mit mittelschwerer oder schwerer hypoxisch-ischämischer Enzephalopathie (HIE), die mittels induzierter Hypoxie behandelt wurden. Besonders im 24-Stunden-EEG und der MRT konnten relevante Hinweise gefunden werden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.